Dalmeet Singh Chawla is a freelance science journalist based in London. His work has been featured in Nature, Science, Slate, Undark, The Economist, New Scientist and Pacific Standard, among other publications. See more about his work here: www.dalmeets.com.
Dalmeet Singh Chawla
Contributing writer
From this contributor
Faked results lead to retraction of high-profile cancer neuroscience study
An investigation found that the experiments required more animals than the scientists had purchased.
Faked results lead to retraction of high-profile cancer neuroscience study
By
Dalmeet Singh Chawla
18 June 2024 | 4 min read
‘Tainted kids,’ other odd phrases cropping up in autism studies
The “tortured phrases” — strangely worded paraphrases of established terms — may be the work of software that attempts to disguise plagiarism.
‘Tainted kids,’ other odd phrases cropping up in autism studies
By
Dalmeet Singh Chawla
2 May 2022 | 4 min read
Why was a study about autism cited by a paper on plant beauty?
Autism studies are appearing in the reference lists of entirely unrelated papers, suggesting what a few scholars worry is a plot to manipulate citations.
Why was a study about autism cited by a paper on plant beauty?
By
Dalmeet Singh Chawla
21 January 2022 | 5 min read
Large study supports discarding the term ‘high-functioning autism’
Autistic people described as ‘high functioning’ because they do not have intellectual disability often still struggle with daily living skills.
Large study supports discarding the term ‘high-functioning autism’
By
Dalmeet Singh Chawla
3 July 2019 | 3 min read
Data analysis, open access could improve peer-review process
Data analysis can improve the vetting of scientific papers, but first publishers must agree to make the information public.
Data analysis, open access could improve peer-review process
By
Dalmeet Singh Chawla, Undark
26 June 2019 | 7 min read
Explore more from The Transmitter
Reporter’s notebook: Highlights from INSAR 2025
The annual meeting brought autism researchers, advocates and clinicians to Seattle to discuss the latest research, including attempts to define subgroups, a potential new CHD8 macaque model and life expectancy gaps.
Reporter’s notebook: Highlights from INSAR 2025
The annual meeting brought autism researchers, advocates and clinicians to Seattle to discuss the latest research, including attempts to define subgroups, a potential new CHD8 macaque model and life expectancy gaps.
By
Daisy Yuhas
15 May 2025 | 5 min read
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
By
Calli McMurray
14 May 2025 | 4 min read
‘We still exist’: How four neuroscience advocacy groups are navigating federal DEI funding cuts
Trainees from underrepresented backgrounds are losing pillars of support in the current funding climate. Grassroots mentorship organizations are stepping in to continue championing early-career researchers.
‘We still exist’: How four neuroscience advocacy groups are navigating federal DEI funding cuts
Trainees from underrepresented backgrounds are losing pillars of support in the current funding climate. Grassroots mentorship organizations are stepping in to continue championing early-career researchers.
By
Paige Miranda
14 May 2025 | 2 min read